Test Price
2,800 AED✅ Home Collection Available
DLX3 Gene Trichodentoosseous Syndrome Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل الجين DLX3 لمتلازمة الشعر والأسنان والعظام (TDO) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الموثوقية والخدمات المتميزة
- ✓ ضمان الدقة: حساسية تشخيصية بنسبة 99.9% عبر معالجة معتمدة من ISO 9001:2015.
- ✓ الخدمات اللوجستية الفاخرة: سحب دم منزلي بمعايير المستشفى عبر سلسلة تبريد معتمدة ISO، مع خدمة سحب الدم المتنقلة VIP.
- ✓ الإرشاد السريري: استشارة هاتفية بعد الفحص من قبل أطباء متخصصين لتفسير النتيجة.
- ✓ التأمين: التحقق المباشر من التغطية التأمينية عبر واتساب +971 54 548 8731.
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing. Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy. Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation. Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Overview / نظرة عامة
The DLX3 Gene Trichodentoosseous Syndrome NGS Test provides definitive molecular diagnosis by sequencing the entire coding region of the DLX3 gene with >99.9% nucleotide accuracy, enabling precise identification of pathogenic variants responsible for the rare autosomal dominant ectodermal dysplasia. يقدم هذا الاختبار الجيني المتطور تشخيصًا جزيئيًا دقيقًا لمتلازمة TDO التي تتميز بشعر مجعد وهش وتشوهات الأسنان وزيادة كثافة العظام، مع نتائج خلال 3-4 أسابيع.
| Feature | Our Test (NGS Diagnostic) | Closest Alternative (Single-Gene Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% nucleotide accuracy, full gene coverage | 99.0% limited to selected exons only |
| Methodology | Next‑Generation Sequencing (Illumina NovaSeq X, 100× mean depth) | Capillary electrophoresis – slower, less comprehensive |
| Speed | 3–4 weeks | 6–8 weeks |
| Clinical Report | Full variant interpretation, ACMG classification, pedigree analysis | Basic mutation call without comprehensive annotation |
| Regulatory Compliance | DHA/MOHAP, ISO 9001:2015, UAE PDPL | Limited to international accreditation only |
Regulatory Compliance & Accreditation
- UAE Federal Decree-Law No. 41 of 2024, Article 87: All genetic testing services adhere to patient data sovereignty and informed consent mandates.
- CDS Law 2026 (Minors): Explicit parental/guardian consent and mandatory genetic counselling are required for testing individuals below 18 years.
- UAE PDPL: Personal genetic information is encrypted, stored locally in UAE‑based servers, and never shared without legal authorisation.
- ISO 9001:2015 Certified: Certificate No. INT/EGQ/2509DA/3139 ensures robust quality management across all laboratory processes.
- Facility License: 9834453 – authorised by the relevant health authority.
Physician Insight & Safety Protocol
“As a clinician, I remind every patient that a genetic result is a piece of your health puzzle, not a standalone verdict. The DLX3 test must be interpreted alongside your full clinical picture, family history, and a qualified genetic counsellor’s guidance. A positive finding does not guarantee disease onset, and a negative result does not completely rule out all genetic abnormalities.”
— Dr. Prabhakar Reddy, DHA License No. 61713011, Senior Clinical Geneticist
Medication & Safety Warning
Do not discontinue any prescribed medication without consulting your treating physician. Genetic testing does not impact your current treatment regimen.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Acute febrile illness, recent blood transfusion (less than 4 weeks), ongoing anticoagulant therapy requiring interruption without medical supervision.
- ER Red Flags: Severe, persistent bleeding at the collection site; sudden dizziness or fainting; signs of infection (redness, swelling, warmth); any allergic reaction such as rash or difficulty breathing. Seek immediate medical help.
Patient FAQ & Clinical Guidance
1. What is the DLX3 Gene Trichodentoosseous Syndrome NGS Test and who should consider it?
This advanced genetic test sequences the entire DLX3 gene to detect mutations causing trichodentoosseous syndrome, a rare ectodermal dysplasia affecting hair, teeth, and bones, within 3–4 weeks. It is recommended for individuals with clinical signs such as kinked hair, dental anomalies (taurodontism, enamel defects), increased bone density, and for at‑risk family members to confirm carrier status or guide reproductive planning.
2. كيف يتم جمع العينة وما هي متطلبات ما قبل الفحص؟
يُجمع الاختبار من خلال عينة دم بسيطة أو قطرة دم على بطاقة FTA، ولا يتطلب أي صيام أو إيقاف للأدوية. تُعد جلسة الاستشارة الوراثية ضرورية قبل الاختبار لرسم شجرة العائلة وتوثيق التاريخ الطبي للمتلازمة بين الأقارب، وذلك لضمان التفسير الصحيح للنتيجة. توفر خدمة السحب المنزلي المريحة للمرضى غير القادرين على الحضور.
3. How accurate are the results and what happens after I receive my report?
Our ISO‑certified NGS methodology delivers 99.9% diagnostic sensitivity for single nucleotide variants and small insertions/deletions in the DLX3 gene, validated by orthogonal confirmation. Post‑, you will receive a telephonic consultation with a clinical geneticist from our team who explains the clinical significance of the findings, possible implications for family members, and recommends follow‑up with a dermatologist, dental specialist, or genetic counsellor through our integrated care network.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians